Back
Alibaba Group Holding Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
90
BABAF
Alibaba Group Holding
Last Price:
$17.39
Seasonality Move:
7.61%
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
$98.13
Seasonality Move:
6.73%
Buy
90
Alibaba Group Holding (BABAF)
is a Buy
Is Alibaba Group Holding a Buy, Sell or Hold?
-
The current Alibaba Group Holding [BABAF] share price is $16.73. The Score for BABAF is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
BABAF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BABAF Stock Price Chart
What is Alibaba Group Holding's stock price today?
-
The Alibaba Group Holding share price today is $16.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BABAF is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $99.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
BABAF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.19 | Buy |
Relative Strength Index (14 RSI): | 55.81 | Buy |
Chaikin Money Flow: | -244452 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.58 - 17.56) | Buy |
Bollinger Bands (100): | (10.09 - 14.59) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.4 | Sell |
Relative Strength Index (14 RSI): | 37.2 | Sell |
Chaikin Money Flow: | -420668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.16 - 112.22) | Sell |
Bollinger Bands (100): | (109.63 - 127.19) | Sell |
BABAF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.95 | Sell |
20-day SMA: | 16.33 | Buy |
50-day SMA: | 13.26 | Buy |
200-day SMA: | 11.3 | Buy |
8-day EMA: | 17.06 | Sell |
20-day EMA: | 16.13 | Buy |
50-day EMA: | 14.21 | Buy |
200-day EMA: | 11.83 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.49 | Sell |
20-day SMA: | 106.07 | Sell |
50-day SMA: | 113.88 | Sell |
200-day SMA: | 126.52 | Sell |
8-day EMA: | 103.1 | Sell |
20-day EMA: | 106.21 | Sell |
50-day EMA: | 111.8 | Sell |
200-day EMA: | 120.79 | Sell |
Alibaba Group Holding Earnings Growth & BABAF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
Alibaba Group Holding Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |